Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination

McCluskey, A. and Boyd, Marie and Pimlott, S.L. and Babich, J.W. and Gaze, M.N. and Mairs, R.J. (2008) Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combination. British Journal of Radiology, 81 (S1). S28-S35. ISSN 0007-1285

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

The radiopharmaceutical [I-131]meta-iodobenzylguanidine ([I-131]MIBG) and the topoisomerase I inhibitor topotecan are both effective as single-agent treatments of neuroblastoma. Our purpose was to assess the therapeutic potential of [I-131]MIBG and topotecan in combination using SK-N-BE(2c) neuroblastoma cells and UVW/NAT glioma cells expressing the noradrenaline transporter transgene. Topotecan treatment was given (i) before, (ii) after or (iii) simultaneously with [I-131]MIBG. DNA fragmentation was evaluated by comet assay and cell cycle redistribution was determined by fluorescence-activated cell sorting. Combination index analysis indicated that delivery schedules (ii) and (iii) were more effective than schedule (i) with respect to clonogenic cell kill. Similarly, significant DNA damage was observed following treatment schedules (ii) and (iii) (p <0.005), but not (i). Prior exposure to topotecan did not significantly enhance [I-131]MIBG uptake in athymic mice bearing tumour xenografts. We conclude that the enhancement of the efficacy of [I-131]MIBG by combining it with topotecan was the result of inhibition of DNA damage repair rather than an increase in expression of the noradrenaline transporter by tumour.

Item type: Article
ID code: 26023
Keywords: noradrenaline transporter, beta-lapachone, damage repair, camptothecin, inhibitors, therapy, Pharmacy and materia medica, Therapeutics. Pharmacology, Radiology Nuclear Medicine and imaging
Subjects: Medicine > Pharmacy and materia medica
Medicine > Therapeutics. Pharmacology
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
    Depositing user: Strathprints Administrator
    Date Deposited: 19 Aug 2010 16:34
    Last modified: 05 Sep 2014 04:58
    URI: http://strathprints.strath.ac.uk/id/eprint/26023

    Actions (login required)

    View Item